Immunotherapy for Malignant Glioma: Current Status and Future Directions

被引:130
作者
Wang, Hongxiang [1 ]
Xu, Tao [1 ]
Huang, Qilin [1 ,2 ]
Jin, Weilin [3 ,4 ]
Chen, Juxiang [1 ]
机构
[1] Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai 200003, Peoples R China
[2] Gen Hosp Cent Theater Command Chinese Peoples Lib, Dept Neurosurg, Wuhan 430070, Peoples R China
[3] Shanghai Jiao Tong Univ, Inst Nano Biomed & Engn, Key Lab Thin Film & Microfabricat Technol, Minist Educ,Dept Instrument Sci & Engn,Sch Elect, Shanghai 200240, Peoples R China
[4] Guilin Med Univ, Affiliated Hosp, Ctr Translat Med, Guilin 541004, Peoples R China
基金
中国国家自然科学基金;
关键词
LONG-TERM SURVIVAL; T-CELLS; MACROPHAGE POLARIZATION; TUMOR MICROENVIRONMENT; CHECKPOINT BLOCKADE; MISMATCH REPAIR; STEM-CELLS; GLIOBLASTOMA; TEMOZOLOMIDE; COMBINATION;
D O I
10.1016/j.tips.2019.12.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glioma is the most common intracranial primary malignancy, with limited treatment options and a poor overall survival (OS). Immunotherapy has been used successfully in various cancers, leading to the development of similar therapies that activate the patient's immune system to eliminate glioma. In this review, we introduce the diverse immunotherapeutic approaches available for treating glioma, highlighting the successes and challenges resulting from current clinical trials. Additionally, we emphasize the effect of multiple clinical factors on immunotherapy to help optimize individualized treatment regimens. Finally, we also highlight several novel concepts and technologies that could be used to design new and/or improve existing immunotherapies. Such approaches will delineate a new blueprint for glioma treatment.
引用
收藏
页码:123 / 138
页数:16
相关论文
共 105 条
[91]   Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells [J].
Walton, Ross W. ;
Brown, Michael C. ;
Sacco, Matthew T. ;
Gromeier, Matthias .
JOURNAL OF VIROLOGY, 2018, 92 (19)
[92]   Clonal evolution of glioblastoma under therapy [J].
Wang, Jiguang ;
Cazzato, Emanuela ;
Ladewig, Erik ;
Frattini, Veronique ;
Rosenbloom, Daniel I. S. ;
Zairis, Sakellarios ;
Abate, Francesco ;
Liu, Zhaoqi ;
Elliott, Oliver ;
Shin, Yong-Jae ;
Lee, Jin-Ku ;
Lee, In-Hee ;
Park, Woong-Yang ;
Eoli, Marica ;
Blumberg, Andrew J. ;
Lasorella, Anna ;
Nam, Do-Hyun ;
Finocchiaro, Gaetano ;
Iavarone, Antonio ;
Rabadan, Raul .
NATURE GENETICS, 2016, 48 (07) :768-+
[93]   Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade [J].
Wang, Ziming ;
Aguilar, Ethan G. ;
Luna, Jesus I. ;
Dunai, Cordelia ;
Khuat, Lam T. ;
Le, Catherine T. ;
Mirsoian, Annie ;
Minnar, Christine M. ;
Stoffel, Kevin M. ;
Sturgill, Ian R. ;
Grossenbacher, Steven K. ;
Withers, Sita S. ;
Rebhun, Robert B. ;
Hartigan-O'Connor, Dennis J. ;
Mendez-Lagares, Gema ;
Tarantal, Alice F. ;
Isseroff, R. Rivkah ;
Griffith, Thomas S. ;
Schalper, Kurt A. ;
Merleev, Alexander ;
Saha, Asim ;
Maverakis, Emanual ;
Kelly, Karen ;
Aljumaily, Raid ;
Ibrahimi, Sami ;
Mukherjee, Sarbajit ;
Machiorlatti, Michael ;
Vesely, Sara K. ;
Longo, Dan L. ;
Blazar, Bruce R. ;
Canter, Robert J. ;
Murphy, William J. ;
Monjazeb, Arta M. .
NATURE MEDICINE, 2019, 25 (01) :141-+
[94]   Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial [J].
Weller, Michael ;
Butowski, Nicholas ;
Tran, David D. ;
Recht, Lawrence D. ;
Lim, Michael ;
Hirte, Hal ;
Ashby, Lynn ;
Mechtler, Laszlo ;
Goldlust, Samuel A. ;
Iwamoto, Fabio ;
Drappatz, Jan ;
O'Rourke, Donald M. ;
Wong, Mark ;
Hamilton, Mark G. ;
Finocchiaro, Gaetano ;
Perry, James ;
Wick, Wolfgang ;
Green, Jennifer ;
He, Yi ;
Turner, Christopher D. ;
Yellin, Michael J. ;
Keler, Tibor ;
Davis, Thomas A. ;
Stupp, Roger ;
Sampson, John H. .
LANCET ONCOLOGY, 2017, 18 (10) :1373-1385
[95]   Vaccine-based immunotherapeutic approaches to gliomas and beyond [J].
Weller, Michael ;
Roth, Patrick ;
Preusser, Matthias ;
Wick, Wolfgang ;
Reardon, David A. ;
Platten, Michael ;
Sampson, John H. .
NATURE REVIEWS NEUROLOGY, 2017, 13 (06) :363-374
[96]   xtended disease-free interval of 6 years in a recurrent glioblastoma multiforme patient treated with G207 oncolytic viral therapy [J].
Whisenhunt, Thomas R., Jr. ;
Rajneesh, Kiran F. ;
Hackney, James R. ;
Markert, James M. .
ONCOLYTIC VIROTHERAPY, 2015, 4 :33-38
[97]   Optogenetic control of chemokine receptor signal and T-cell migration [J].
Xu, Yuexin ;
Hyun, Young-Min ;
Lim, Kihong ;
Lee, Hyunwook ;
Cummings, Ryan J. ;
Gerber, Scott A. ;
Bae, Seyeon ;
Cho, Thomas Yoonsang ;
Lord, Edith M. ;
Kim, Minsoo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (17) :6371-6376
[98]   Immune cells track hard-to-target tumours [J].
Zaidi, Neeha ;
Jaffee, Elizabeth M. .
NATURE, 2019, 565 (7738) :170-171
[99]   Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas [J].
Zeng, Jing ;
See, Alfred P. ;
Phallen, Jillian ;
Jackson, Christopher M. ;
Belcaid, Zineb ;
Ruzevick, Jacob ;
Durham, Nicholas ;
Meyer, Christian ;
Harris, Timothy J. ;
Albesiano, Emilia ;
Pradilla, Gustavo ;
Ford, Eric ;
Wong, John ;
Hammers, Hans-Joerg ;
Mathios, Dimitris ;
Tyler, Betty ;
Brem, Henry ;
Tran, Phuoc T. ;
Pardoll, Drew ;
Drake, Charles G. ;
Lim, Michael .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02) :343-349
[100]   ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma [J].
Zhang, Congcong ;
Burger, Michael C. ;
Jennewein, Lukas ;
Genssler, Sabrina ;
Schoenfeld, Kurt ;
Zeiner, Pia ;
Hattingen, Elke ;
Harter, Patrick N. ;
Mittelbronn, Michel ;
Tonn, Torsten ;
Steinbach, Joachim P. ;
Wels, Winfried S. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (05)